David Stern, MBA
CEO Boston IVF
David Stern has over 28 years of women’s health experience and has devoted much of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide.
Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full-service IVF centers and over 30 satellite centers nationwide.
David served as CEO of Symbiomix Therapeutics; a venture backed biotech company. He led the transition of the company from development stage to commercial launch in the US, prior to its acquisition by Lupin Pharmaceuticals in 2017. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy, and expanding scientific partnerships for Celmatix, Ohana, and OvaScience.
As the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, David was responsible for the strategic development and growth of the portfolio world-wide. Prior to his global role, he was responsible for the US commercial operations in the Fertility, HIV and Growth Hormone markets. David started his career in women’s health with Organon Pharmaceutics. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a bachelor’s degree in biology from Brandeis University.
Janene Oleaga, Esq
Reproductive Attny, Oleaga Law LLC
Janene’s extensive history of family building advocacy makes her a perfect fit to help steer the BIVF Foundation forward and address longstanding, systemic inequities in family building care.
An assisted reproduction and adoption attorney and reproductive rights advocate, Janene founded Oleaga Law LLC to guide and protect her clients as they navigate surrogacy arrangements, egg/sperm donation, embryo donation, embryo disposition, and all methods of securing legal parentage including confirmatory adoptions and pre-birth/post-birth judgments of parentage.
She has testified in support of pro-family legislation at both state and federal levels – and is a member of a numerous organizations dedicated to advocating for reproductive rights, including the ABA Adoption Committee, ASRM Legal Professional Ground, New England Fertility Society, National LGBTQ+ Bar Foundation, Men Having Babies, Resolve, and more.
Michael Alper, MD
Medical Director, Boston IVF
Dr. Michael Alper co-founded Boston IVF in 1986. For almost three decades, he has lead Boston IVF as its Medical Director, where he continues to deliver personalized care to help patients achieve their family building goals.
Dr. Alper is double board-certified in Obstetrics and Gynecology/Reproductive Endocrinology and Infertility. He specializes in all aspects of fertility care.
Additionally, Dr. Alper is an Associate Clinical Professor in the Department of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School, where he teaches the next generation of fertility experts and performs crucial research to improve future care. He contributes to infertility articles, abstracts, letters, and actively lectures at scientific meetings throughout the world.
Dr. Alper’s main interest of in vitro fertilization has led him to be involved in many research studies and scientific contribution. Dr. Alper’s professional focus has been quality standards in IVF and methods to improve the efficiency and acceptance of fertility treatments. He has lead Boston IVF to become the only ISO-certified IVF Center in North America and has written extensively on the standards for quality and safety in the field.
Kori Ricketts
Sr. Director of Equity/CultureKori Ricketts is a recent graduate of the Harvard Graduate School of education with her doctoral degree in Education Leadership.
She is the current Senior Director of Equity and Culture at NARAL Pro- Choice America.
Her connection to the BIVF Foundation is seeded in her own infertility journey and experiences and the success she experienced as a patient at Boston IVF. She brings to the Foundation her commitment to equity and passion for reproductive access for all.
Serene Srouji, MD
Medical Director, Brigham and Women’s Center for Infertility
Dr. Serene Samir Srouji is the Medical Director at the Brigham and Women’s Center for Infertility and Reproductive Surgery, the Medical Director of the hospital’s Assisted Reproductive Technologies Program, and the Associate Director for Robotic Surgery in Reproductive Endocrinology.
Double board-certified in obstetrics/gynecology and reproductive endocrinology/infertility – she has 20+ years of clinical experience and specializes in a full array of fertility treatments. Alongside her clinical role, Dr. Srouji is an Associate Professor at Harvard Medical School.
Her clinical and research interests include assisted reproductive technologies, IVF, fibroids, gynecologic laparoscopic surgery, hysteroscopic surgery, infertility, LGBTQ+ health, robotic surgery, and more.
Dr. Srouji received her medical degree from Johns Hopkins University School of Medicine. She completed her residency training in Obstetrics and Gynecology at the University of Washington Hospitals. She then completed fellowship training in Reproductive Endocrinology and Infertility at Brigham and Women’s Hospital in Boston.
Alan Penzias, MD
REI Fellowship Director,
Beth Israel Deaconess Medical Center,
Boston IVF
Dr. Alan Penzias is a reproductive endocrinologist at Boston IVF. He is double board-certified in Obstetrics and Gynecology/Reproductive Endocrinology and fertility. In 2021, he joined the American Society for Reproductive Medicine (ASRM) board of directors.
He specializes in all aspects of fertility care.
Additionally, Dr. Penzias is an Associate Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and the Director of the Fellowship Program in Reproductive Endocrinology and Infertility at Beth Israel Deaconess Medical Center/Harvard Medical School.
A past president of the New England Fertility Society, Dr. Penzias has served as a member of the executive council for SART (The Society of Assisted Reproductive Technology) and currently serves on the Practice Committee and the Embryo Transfer Simulator Advisory Panel for the American Society for Reproductive Medicine. He is a member of the World Health Organization Infertility Global Guidelines and Research Group and a member of the scientific committee of the Updates in Infertility Treatments group under the auspices of the International Federation of Fertility Societies (IFFS). He is a former associate editor and current member of the Editorial Board of Fertility and Sterility and Emeritus Editorial Board of Reproductive Biomedicine Online.
In 2021, Dr. Penzias joined the American Society for Reproductive Medicine (ASRM) board of directors.